Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Survival of selected patients with ovarian cancer treated with fertility-sparing surgery

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pregnancy outcomes after recurrent pregnancy loss: a longitudinal cohort study on stress and depression

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Serum anti-Müllerian hormone concentration before and after salpingectomy for ectopic pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Investigation of anti-Müllerian hormone concentrations in relation to natural conception rate and time to pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Luteal phase progesterone and oestradiol after ovarian stimulation: relation to response and prediction of pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Low oocyte yield during IVF treatment and the risk of a trisomic pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The genetic landscape of 87 ovarian germ cell tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

RESEARCH QUESTION: How many patients in Denmark were treated with fertility-sparing surgery (FSS) for epithelial ovarian cancer (EOC) and what was their prognosis compared with patients treated with radical surgery (RS)?

DESIGN: This study was a retrospective Danish nationwide study, evaluating the effect of FSS compared with RS in patients with EOC, age ≤45 years and International Federation of Gynecology and Obstetrics (FIGO) stage ≤IC3 from 2005 to 2016.

RESULTS: A total of 106 patients were included. Of these, 13 were treated with FSS and 93 were treated with RS. Median age was 27 versus 42 years (P < 0.0001). Overall survival did not differ significantly between the two groups. Overall survival rate in the FSS group was 100%, while the overall survival in the RS group was 87%. Disease-specific survival was 100% in the FSS group and 91% in the RS group.

CONCLUSIONS: This study shows that patients treated with FSS for FIGO stage I EOC do not have an impaired survival compared with patients treated with RS. Nevertheless, the conclusion must be interpreted with caution due to the limited number of patients and the retrospective nature of the study. Larger studies are needed before conclusions can be drawn.

Original languageEnglish
JournalReproductive BioMedicine Online
Volume37
Issue number1
Pages (from-to)71-76
Number of pages6
ISSN1472-6483
DOIs
Publication statusPublished - Jul 2018

    Research areas

  • Adolescent, Adult, Denmark, Disease-Free Survival, Female, Fertility Preservation/methods, Humans, Middle Aged, Neoplasms, Glandular and Epithelial/mortality, Organ Sparing Treatments/methods, Ovarian Neoplasms/mortality, Prognosis, Retrospective Studies, Survival Rate, Treatment Outcome, Young Adult

ID: 55852291